STOCK TITAN

Assure Holdings Announces 2022 Record Date for Annual Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Assure Holdings Corp. (NASDAQ: IONM) announced that shareholders recorded by November 18, 2022, can vote at the Annual Meeting set for December 28, 2022. The notice will be mailed around November 28, 2022. Assure is a leading provider of intraoperative neuromonitoring and remote neurology services, supporting various surgical procedures while ensuring patient safety and care. The company emphasizes its commitment to exceptional surgical outcomes and patient experiences, backed by a team of trained technologists and accredited operations.

Positive
  • Shareholders are notified of the upcoming Annual Meeting, allowing engagement in corporate governance.
  • Assure is recognized as a provider of outsourced intraoperative neuromonitoring, indicating its strong market position.
Negative
  • The PR highlights uncertainties related to operational impacts from COVID-19, which may affect business performance.

DENVER, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that shareholders of record as of the close of business on November 18, 2022, will be entitled to notice of, and to vote at, the Annual Meeting of Shareholders to be held on December 28, 2022. The Company anticipates that the notice of the Annual Meeting of Shareholders will be mailed to shareholders on or about November 28, 2022. 

About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: the anticipated timing for mailing notice of the Annual Meeting to stockholders and the anticipated date for the Annual Meeting. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-617-2526
Scott.Kozak@assureiom.com


FAQ

What is the date for Assure Holdings' Annual Meeting in 2022?

The Annual Meeting for Assure Holdings is scheduled for December 28, 2022.

Who can vote at the Annual Meeting for Assure Holdings?

Shareholders of record as of November 18, 2022, are entitled to vote.

When will the notice for the Annual Meeting be mailed to shareholders?

The notice is expected to be mailed on or around November 28, 2022.

What services does Assure Holdings provide?

Assure Holdings provides intraoperative neuromonitoring and remote neurology services for various surgical procedures.

ASSURE HLDGS CORP

OTC:IONM

IONM Rankings

IONM Latest News

IONM Stock Data

365.19k
2.99M
4.46%
32.33%
Medical Care Facilities
Surgical & Medical Instruments & Apparatus
Link
United States of America
GREENWOOD VILLAGE